Skip to main content
Log in

Analysis of the Application of MMP-9 Inhibitor in Skin Melanoma: Experimental Study

  • General Pathology and Pathophysiology
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Experiment on C57Bl/6 mice with modeled skin melanoma showed that selective inhibition of matrix metalloproteinase-9 increased lifetime and reduced the number of PCNA+ tumor cells and intensity of neoangiogenesis. Inhibition of matrix metalloproteinase-9 prevented tumor necrosis. The results suggest that matrix metalloproteinase-9 is involved not only in the regulation of extracellular matrix degradation, but also in the processes of cell proliferation and neoangiogenesis in skin melanoma. Therefore, this enzyme can be considered as a potential therapeutic target.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. B. B. Aggarwal, M. E. Van Kuiken, L. H. Iyer, et al., Exp. Biol. Med. (Maywood), 234, No. 8, 825–849 (2009).

    Article  CAS  Google Scholar 

  2. F. Bianchini, S. D’Allesio, G. Fibbi, et al., Oncol. Rep., 15, No. 3, 709–714 (2006).

    PubMed  CAS  Google Scholar 

  3. M. Cheng, B. De, S. Pikul, et al., J. Med. Chem., 43, No. 3, 369–380 (2000).

    Article  PubMed  CAS  Google Scholar 

  4. C. A. Fernandez, M. F. Wszolek, K. R. Loughlin, et al., J. Urol., 182, No. 5, 2188–2944 (2009).

    Article  PubMed  CAS  Google Scholar 

  5. U. B. Hoffman, J. R. Westphal , G. N. Van Muijen, and D. R. Ruiter, J. Invest. Dermatol., 115, No. 3, 337–344 (2000).

    Article  Google Scholar 

  6. M. Kanjoormana and G. Kuttan, Integr. Cancer Ther., 9, No. 2, 224–235 (2010).

    Article  PubMed  CAS  Google Scholar 

  7. M. Lempinen, K. Inkinen, H. Wolff, and J. Ahonen, Eur. Surg. Res., 32, No. 3, 169–176 (2000).

    Article  PubMed  CAS  Google Scholar 

  8. Y. Liu, D. Min, T. Bolton, et al., Diabetes Care, 32, N 1, 117–119 (2009).

    Article  PubMed  CAS  Google Scholar 

  9. J. R. Mac Dougall, M. R. Ban, Y. Li, et al., Br. J. Cancer, 80, Nos. 3–4, 504–512 (1999).

    Article  CAS  Google Scholar 

  10. H. Mulder, J. Endocrinol., 10, 1530 (2011).

    Google Scholar 

  11. B. V. Offersen, M. M. Knap, and M. R. Horsman, Acta. Oncol., 49, No. 8, 1283–1287 (2010).

    Article  PubMed  CAS  Google Scholar 

  12. T. Sakimoto, J. Shoji, and M. Saws, Jpn. J. Ophthalmol., 47, No. 5, 423–426 (2003).

    Article  PubMed  CAS  Google Scholar 

  13. M. D. Sternlicht and Z. Werb, Annu. Rev. Cell Dev. Biol., 17, 463–516 (2001).

    Article  PubMed  CAS  Google Scholar 

  14. B. Sun, S. Zhang, D. Zhang, X. Yin, et al., Exp. Biol. Med. (Maywood), 232, No. 10, 1300–1307 (2007).

    Article  CAS  Google Scholar 

  15. T. Szarvas, F. Vom Dorp, S. Ergun, et al., Nat. Rev. Urol., 8, No. 5, 241–254 (2011).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. G. Ruksha.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 154, No. 11, pp. 547-549, November, 2012

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aksenenko, M.B., Ruksha, T.G. Analysis of the Application of MMP-9 Inhibitor in Skin Melanoma: Experimental Study. Bull Exp Biol Med 154, 594–596 (2013). https://doi.org/10.1007/s10517-013-2007-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-013-2007-6

Key Words

Navigation